Drug intelligence / Profile preview

acellular adipose tissue

Development stage
Phase 2
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Cell Therapies, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Surgical Implantation, Injection
01

Overview

Acellular adipose tissue, also known as acellular adipose matrix (AAM), is a biologically derived scaffold created by removing cellular components and lipids from human or animal adipose (fat) tissue while preserving the native extracellular matrix (ECM) structure and associated growth factors. The resulting product contains structural proteins such as collagen type I, collagen type IV, laminin, and various bioactive molecules that support cell adhesion, proliferation, angiogenesis, and in vivo induction of new fat cell formation (adipogenesis). AAM is used primarily for soft tissue reconstruction in settings such as congenital defects, trauma repair, cancer care reconstruction, or cosmetic procedures. When implanted or injected into the body, AAM serves as a scaffold for host cells—especially stem cells—to migrate into the site and regenerate new soft tissue with improved volume retention compared to traditional autologous fat grafting. Because it lacks living cells or immunogenic material from donors after processing, AAM reduces risks of immune rejection and necrosis seen with conventional grafts[1][4][5][6]. Research supports its safety profile and effectiveness in promoting soft-tissue regeneration; however clinical data are still limited.

Other names
acellular adipose matrixAAMadipose tissue-derived extracellular matrixallograft adipose matrix
02

Targets

Integrin (Integrin family)

Beyond the preview

Go deeper on acellular adipose tissue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acellular adipose tissue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call